Next Article in Journal / Special Issue
Japan’s Ongoing Crisis on HPV Vaccination
Previous Article in Journal
Tetravalent Immunogen Assembled from Conserved Regions of HIV-1 and Delivered as mRNA Demonstrates Potent Preclinical T-Cell Immunogenicity and Breadth
Previous Article in Special Issue
Heterologous Combination of ChAdOx1 and MVA Vectors Expressing Protein NS1 as Vaccination Strategy to Induce Durable and Cross-Protective CD8+ T Cell Immunity to Bluetongue Virus
 
 
Review

Prospects and Challenges in the Development of Universal Influenza Vaccines

1
Influenza Centre, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway
2
Department of Microbiology, Haukeland University Hospital, 5021 Bergen, Norway
*
Author to whom correspondence should be addressed.
Vaccines 2020, 8(3), 361; https://doi.org/10.3390/vaccines8030361
Received: 5 June 2020 / Revised: 29 June 2020 / Accepted: 30 June 2020 / Published: 6 July 2020
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)
Current influenza vaccines offer suboptimal protection and depend on annual reformulation and yearly administration. Vaccine technology has rapidly advanced during the last decade, facilitating development of next-generation influenza vaccines that can target a broader range of influenza viruses. The development and licensure of a universal influenza vaccine could provide a game changing option for the control of influenza by protecting against all influenza A and B viruses. Here we review important findings and considerations regarding the development of universal influenza vaccines and what we can learn from this moving forward with a SARS-CoV-2 vaccine design. View Full-Text
Keywords: influenza; vaccine; next-generation vaccine influenza; vaccine; next-generation vaccine
Show Figures

Figure 1

MDPI and ACS Style

Madsen, A.; Cox, R.J. Prospects and Challenges in the Development of Universal Influenza Vaccines. Vaccines 2020, 8, 361. https://doi.org/10.3390/vaccines8030361

AMA Style

Madsen A, Cox RJ. Prospects and Challenges in the Development of Universal Influenza Vaccines. Vaccines. 2020; 8(3):361. https://doi.org/10.3390/vaccines8030361

Chicago/Turabian Style

Madsen, Anders, and Rebecca Jane Cox. 2020. "Prospects and Challenges in the Development of Universal Influenza Vaccines" Vaccines 8, no. 3: 361. https://doi.org/10.3390/vaccines8030361

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop